Chris completed his PhD in 2017 at the Peter Doherty Institute investigating the requirements for protective immunity to localized mucosal infections. His postdoctoral work has involved characterizing novel unconventional T cells at both the Doherty and the Murdoch Children’s Research Institute and has recently moved to the Hudson Institute of Medical Research to investigate novel therapies for respiratory infections.